Transcat Acquires Southeastern Biomedical for $12.8M to Expand…

Event summary

Transcat acquired Southeastern Biomedical for $12.8M in cash on August 31, 2026.
Southeastern, founded in 1996, provides calibration, repair, and compliance services to healthcare facilities in the southeastern U.S.
The deal extends Transcat's biomedical calibration capabilities and geographic reach.
Transcat now operates over 30 calibration labs across North and Central America.
Southeastern's co-owners Boyd Campbell and Greg Johnson will join Transcat.

The big picture

Transcat's acquisition of Southeastern Biomedical aligns with its strategy of building scale in high-cost-of-failure, regulated markets like healthcare. The deal enhances Transcat's ability to provide accredited calibration services critical to patient safety and regulatory compliance, positioning it as a key player in the growing biomedical calibration sector. With over 30 calibration labs, Transcat is expanding its footprint to better serve hospital networks and other regulated customers across a broader geography.

What we're watching

Integration Challenges: How Transcat will merge Southeastern's operations and culture into its existing biomedical division.
Market Expansion: Whether the acquisition will accelerate Transcat's growth in the regulated healthcare sector.
Competitive Positioning: The pace at which Transcat can leverage this deal to strengthen its position against competitors in biomedical calibration.